Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Swine Vaccines Market Size Forecast: How Big Could The Market Get By 2030?
The swine vaccines market has shown substantial growth in its size over recent years. It will grow from $2.37 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to factors like the widespread incidence of viral and bacterial infections among swine, increasing consumer demand for pork products, the expansion of commercial pig farming operations, the development of conventional live and inactivated vaccines, and a rising awareness regarding swine herd health management.
The swine vaccines market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $3.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This expected growth during the forecast period is attributable to several factors, including the increasing adoption of DNA and recombinant vaccines, greater government support for swine vaccination programs, the advancement of precision livestock farming, a heightened focus on emerging infectious diseases, and the expansion of cold-chain infrastructure for vaccine distribution. Major developments characterizing this period include the creation of multi-valent swine vaccines, a stronger emphasis on preventive swine healthcare, continuous progress in DNA and recombinant vaccine technologies, the optimization of cold-chain logistics for vaccine delivery, and the development of rapid-response vaccines for emerging swine diseases.
Get A Free Sample Report With In-Depth Market Insights:
Swine Vaccines Market Growth Backed By Core Demand Fundamentals
The growing incidence of diseases in swine is anticipated to drive the swine vaccine market forward. A swine disease represents any departure from a pig’s usual healthy state, marked by symptoms such as pseudorabies and influenza. The surge in these diseases stems from intensive farming methods, which lead to higher animal concentrations, thereby quickening disease transmission and complicating outbreak management. Swine vaccines effectively address this increasing disease prevalence by boosting the immune system to identify and counteract specific pathogens, leading to fewer infections, less severe illness, and improved overall herd well-being. For example, in December 2023, the Swine Health Information Center, a US-based non-profit organization, reported a concerning rise in African Swine Fever (ASF) cases among wild boars in Poland. By early 2023, Poland had documented 2,347 confirmed ASF cases in wild boars, surpassing the total recorded in 2022. Consequently, the increasing occurrence of swine diseases is projected to fuel market expansion.
Swine Vaccines Market Segment Outlook: Which Categories Are Growing Fastest?
The swine vaccines market covered in this report is segmented –
1) By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
2) By Disease: Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies
4) By Application: Government Tender, Market Sales
Subsegments:
1) By Attenuated Live Vaccines: Live Attenuated Virus Vaccines, Live Attenuated Bacterial Vaccines
2) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
4) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Nucleic Acid Vaccines
5) By Recombinant Vaccines: Recombinant Vector Vaccines, Recombinant Protein Vaccines
Swine Vaccines Market Growth Trends Reshaping The Competitive Landscape
Companies operating within the swine vaccine market are increasingly concentrating on introducing advanced vaccines, such as Circumvent CML, to secure a competitive advantage. Circumvent CML is formulated to safeguard swine herds against various illnesses, thereby boosting overall swine health and output. An illustration of this occurred in June 2023, when Merck Animal Health, a US-based pharmaceutical company, released Circumvent CML, a novel 3-in-one swine vaccine that manages diseases including Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. This latest vaccine incorporates Merck’s established and verified antigen and adjuvant systems, previously utilized in Circumvent PCV-M G2 and their standalone offering, Porcilis Ileitis.
Swine Vaccines Market Company Landscape And Competitive Strategy
Major companies operating in the swine vaccines market are Merck & Co Inc., Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Inc., Biogenesis Bago SA, Phibro Animal Health Corporation, KM Biologics Co. Ltd., Hipra Laboratories SA, Ceva Santé Animale SA, Zoetis Inc., Jinyu Bio-Technology Co. Ltd., China Animal Husbandry Industry Co. Ltd., Virbac SA, Harbin Veterinary Research Institute, Bioveta AS, Bimeda Holdings PLC, Biovac Ltd., Hester Biosciences Limited, Hygieia Biological Laboratories, IDT Biologika GmbH, Intervet Inc., Komipharm International Co. Ltd., Kyoritsu Seiyaku Corporation, Lohmann Animal Health International, Norbrook Laboratories Limited, Ouro Fino Saúde Animal SA, Prondil SA, Vaxxinova International BV, Vetoquinol SA, Veyx Pharma GmbH, Tianjin Ringpu Bio-Technology Co. Ltd.
View The Full Swine Vaccines Market Report:
Swine Vaccines Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the swine vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
